Drug resistant E. coli infections were not halted by reduction, according to new report More: Report finds reducing primary care antibiotic use 'not enough' to halt antimicrobial resistance Source: News
read morePfizer, Flynn face revived U.K. antitrust accusations of ‘unfairly high’ prices on epilepsy drug aliu Thu, 08/05/2021 – 07:25 More: Pfizer, Flynn face revived U.K. antitrust accusations of 'unfairly high' prices on epilepsy drug Source: fierce
read moreNeutralising antibody titers were observed in 98.5% of subjects More: Positive Phase III results for Valneva’s chikungunya vaccine Source: News
read moreAgreement will support use of the ‘best evidence-based healthcare’ in the NHS More: NICE pens two-year collaboration with the Academic Health Science Network Source: News
read moreVaccine side effects rare and outweighed by the benefits More: 16- and 17-year-olds should receive first COVID-19 vaccine, advises JCVI Source: News
read moreArdelyx slashes one-third of its workforce after FDA rejection for key kidney disease prospect fkansteiner Wed, 08/04/2021 – 13:21 More: Ardelyx slashes one-third of its workforce after FDA rejection for key kidney disease prospect Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals